Argentina vs Côte d'Ivoire: Share of one-year-olds vaccinated against Haemophilus influenzae type B
Argentina
75.0%
in 2024
Côte d'Ivoire
77.0%
in 2024
Argentina rank
152nd
Côte d'Ivoire rank
149th
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- Argentina
- Côte d'Ivoire
How they compare
Côte d'Ivoire currently reports 77.0% against 75.0% in Argentina, a difference of 2.0%.
The two have swapped places 1 time across 16 shared years of data; in 2009 it was Argentina ahead.
Argentina ranks 152nd and Côte d'Ivoire ranks 149th of 192 countries.
Argentina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Côte d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.0% | 81.0% | 13.0% | Argentina |
| 2010s | 90.5% | 78.2% | 12.3% | Argentina |
| 2020s | 76.0% | 74.8% | 1.2% | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, Argentina or Côte d'Ivoire?
- Côte d'Ivoire, at 77.0% against 75.0% in Argentina as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between Argentina and Côte d'Ivoire?
- 2.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Argentina and Côte d'Ivoire?
- 16 years are reported by both, from 2009 to 2024.
- How do Argentina and Côte d'Ivoire rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- Argentina ranks 152nd and Côte d'Ivoire ranks 149th of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.